Leptomeningeal metastases: a RANO proposal for response criteria, Neuro Oncol, vol.19, pp.484-492, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02940579
Breast cancer leptomeningeal metastasis-the role of multimodality treatment, J Neurooncol, vol.84, pp.57-62, 2007. ,
Survival of breast cancer patients with meningeal carcinomatosis, Ann Oncol, vol.21, pp.2183-2187, 2010. ,
Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations, Breast Cancer Res Treat, vol.129, pp.809-817, 2011. ,
Meningeal carcinomatosis in breast cancer: prognostic factors and outcome, J Neurooncol, vol.104, pp.565-572, 2011. ,
Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer, Breast J, vol.18, pp.233-241, 2012. ,
Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experience, J Chemother, vol.24, pp.279-284, 2012. ,
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment, J Neurooncol, vol.106, pp.303-313, 2012. ,
Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival, Med Oncol, vol.30, p.408, 2013. ,
Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis, J Neurooncol, vol.114, pp.229-235, 2013. ,
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer, J Neurooncol, vol.113, pp.83-92, 2013. ,
Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy, Clin Breast Cancer, vol.15, pp.66-72, 2015. ,
Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy, J Thorac Oncol, vol.7, pp.382-385, 2012. ,
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era, Lung Cancer, vol.76, pp.387-392, 2012. ,
Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer, J Thorac Oncol, vol.8, pp.599-605, 2013. ,
Leptomeningeal carcinomatosis in nonsmall-cell lung cancer patients: impact on survival and correlated prognostic factors, J Thorac Oncol, vol.8, pp.185-191, 2013. ,
Prolonged survival of patients with nonsmall-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era, Clin Lung Cancer, vol.15, pp.202-206, 2014. ,
Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: a retrospective cohort analysis, Lung Cancer, vol.89, pp.255-261, 2015. ,
Prognostic factors and outcomes in patients with leptomeningeal melanomatosis, Neuro Oncol, vol.10, pp.1010-1018, 2008. ,
Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma, Ann Oncol, vol.27, pp.1138-1142, 2016. ,
Surgical ventricular entry is a key risk factor for leptomeningeal metastasis of high grade gliomas, Sci Rep, vol.5, p.17758, 2015. ,
Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection, J Neurosurg, vol.116, pp.984-993, 2012. ,
Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination, J Neurosurg, vol.80, pp.834-839, 1994. ,
Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: a potentially preventable complication, J Neurooncol, vol.32, pp.215-223, 1997. ,
Leptomeningeal metastasis after surgical resection of brain metastases, J Neurol Neurosurg Psychiatry, vol.66, pp.225-227, 1999. ,
Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis, Neurosurgery, vol.64, pp.674-676, 2009. ,
Surgical resection of brain metastases and the risk of leptomeningeal recurrence in patients treated with stereotactic radiosurgery, Int J Radiat Oncol Biol Phys, vol.94, pp.537-543, 2016. ,
Leptomeningeal disease and breast cancer: the importance of tumor subtype, Breast Cancer Res Treat, vol.146, pp.477-486, 2014. ,
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small-cell lung cancer patients with leptomeningeal carcinomatosis, J Thorac Oncol, vol.10, pp.1754-1761, 2015. ,
Frequent EGFR mutations in brain metastases of lung adenocarcinoma, Int J Cancer, vol.119, pp.1491-1494, 2006. ,
Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations, Int J Clin Oncol, vol.20, pp.674-679, 2015. ,
The central nervous system as a sanctuary site in ALK-positive non-small-cell lung cancer, J Thorac Oncol, vol.8, pp.1570-1573, 2013. ,
Molecular targeted therapies for the treatment of leptomeningeal carcinomatosis: current evidence and future directions, Int J Mol Sci, vol.17, p.1074, 2016. ,
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer, N Engl J Med, vol.368, pp.2385-2394, 2013. ,
Leptomeningeal metastases in the MRI era, Neurology, vol.74, pp.1449-1454, 2010. ,
Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis, J Cancer Res Clin Oncol, vol.136, pp.1729-1735, 2010. ,
Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value, Br J Cancer, vol.91, pp.219-224, 2004. ,
Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy, J Neurooncol, vol.95, pp.421-426, 2009. ,
Leptomeningeal metastasis: clinical experience of 519 cases, Eur J Cancer, vol.56, pp.107-114, 2016. ,
Diffuse involvement of the leptomeninges by tumour-a clinical and pathological study of 63 cases, Postgrad Med J, vol.56, pp.149-158, 1980. ,
, Cancer, vol.37, pp.2906-2911, 1976.
Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid?, Cancer, vol.51, pp.154-160, 1983. ,
Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects, Brain Pathol, vol.25, pp.209-226, 2015. ,
Impact of multimodality approach for patients with leptomeningeal metastases from solid tumors, J Korean Med Sci, vol.29, pp.1094-1101, 2014. ,
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria, Neuro Oncol, vol.19, pp.625-635, 2017. ,
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials, Neuro Oncol, vol.16, pp.1176-1185, 2014. ,
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis, Ann Neurol, vol.38, pp.51-57, 1995. ,
Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrastenhanced MR imaging, Radiology, vol.217, pp.50-53, 2000. ,
The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis, J Neurol, vol.246, pp.810-814, 1999. ,
Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis-a single centre experience, Br J Haematol, vol.124, pp.762-768, 2004. ,
MR imaging of leptomeningeal metastases: comparison of three sequences, AJNR Am J Neuroradiol, vol.23, pp.817-821, 2002. ,
Meninges in cancer imaging, Spec No A:S14-S21, vol.9, 2009. ,
Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches, Oncologist, vol.16, pp.1175-1188, 2011. ,
Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography, Am J Med, vol.73, pp.641-647, 1982. ,
Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status, Cancer, vol.75, pp.2919-2931, 1995. ,
Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results, Cancer, vol.82, pp.733-739, 1998. ,
Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis, Neurology, vol.42, pp.1239-1241, 1992. ,
A standardized protocol for flow cytometric analysis of cells isolated from cerebrospinal fluid, J Neurol Sci, vol.121, pp.74-78, 1994. ,
Thinprep plus Papanicolaou stain method is more sensitive than cytospin-coupled Wright Giems stain method in cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis from solid tumors, PLoS One, vol.10, p.122016, 2015. ,
Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry, J Clin Oncol, vol.27, pp.1462-1469, 2009. ,
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases, Oncotarget, vol.2, pp.752-760, 2011. ,
Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis, BMC Clin Pathol, vol.12, p.21, 2012. ,
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer, Breast Cancer Res Treat, vol.154, pp.339-349, 2015. ,
EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors, Neuro Oncol, vol.18, pp.855-862, 2016. ,
Novel method for the detection and quantification of malignant cells in the CSF of patients with leptomeningeal metastasis of lung cancer, Oncol Lett, vol.11, pp.619-623, 2016. ,
Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis, Clin Exp Metastasis, vol.32, pp.383-391, 2015. ,
CellSearch technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis, Lung Cancer, vol.90, pp.352-357, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02939544
Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors, Genomics Data, vol.2, pp.60-62, 2014. ,
Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases, J Neurooncol, vol.128, pp.93-100, 2016. ,
Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure, Respir Investig, vol.54, pp.14-19, 2016. ,
Detection of epithelial growth factor receptor mutations in cerebrospinal fluid from patients with lung adenocarcinoma suspected of neoplastic meningitis, J Thorac Oncol, vol.6, pp.1215-1220, 2011. ,
Sensitive detection of EGFR mutations in cerebrospinal fluid from lung adenocarcinoma patients with brain metastases, J Mol Diagn, vol.16, issue.5, pp.558-563, 2014. ,
Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe, J Neuro-Oncol, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02940545
blood-brain barrier, and brain drug delivery, Expert Opin Drug Deliv, vol.13, pp.963-975, 2016. ,
The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study, Eur J Cancer, vol.40, pp.2726-2733, 2004. ,
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?, J Clin Oncol, vol.16, pp.1561-1567, 1998. ,
Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy, Cancer, vol.82, pp.1756-1763, 1998. ,
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO), Neuro Oncol, vol.19, pp.162-174, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02940525
Extended survival in women with brain metastases from HER2 overexpressing breast cancer, Am J Clin Oncol, vol.31, pp.250-254, 2008. ,
Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER, Clin Cancer Res, vol.17, pp.4834-4843, 2011. ,
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer, J Clin Oncol, vol.26, pp.1993-1999, 2008. ,
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer, Clin Cancer Res, vol.15, pp.1452-1459, 2009. ,
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies, Br J Cancer, vol.101, pp.1676-1682, 2009. ,
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study, Lancet Oncol, vol.14, pp.64-71, 2013. ,
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine, Ann Oncol, vol.22, pp.625-630, 2011. ,
Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases-the UK experience, Br J Cancer, vol.102, pp.995-1002, 2010. ,
Activity of T-DM1 in Her2-positive breast cancer brain metastases, Clin Exp Metastasis, vol.32, pp.729-737, 2015. ,
Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: a case series, Cancer Treat Commun, vol.7, pp.43-46, 2016. ,
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases, Breast Cancer Res Treat, vol.157, pp.307-318, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02296735
Optimal management of leptomeningeal carcinomatosis in breast cancer patients-a systematic review, Clin Breast Cancer, vol.16, pp.456-470, 2016. ,
Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue, Breast Cancer Res Treat, vol.123, pp.125-128, 2010. ,
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis, BMC Cancer, vol.15, p.299, 2015. ,
Pemetrexed plus platinum as the firstline treatment option for advanced non-small cell lung cancer: a metaanalysis of randomized controlled trials, PLoS One, vol.7, p.37229, 2012. ,
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases, Cancer Treat Rev, vol.40, pp.716-722, 2014. ,
Bevacizumab in patients with nonsquamous non-small cell lung cancer and asymptomatic, untreated brain metastases (BRAIN): a nonrandomized, phase II study, Clin Cancer Res, vol.21, pp.1896-1903, 2015. ,
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT), Lancet, vol.387, pp.1415-1426, 2016. ,
Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group, Lung Cancer, vol.77, pp.134-139, 2012. ,
High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs, Cancer Chemother Pharmacol, vol.75, pp.1261-1266, 2015. ,
A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer, Oncotarget, vol.6, pp.4527-4536, 2015. ,
Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib, Int J Clin Oncol, vol.17, pp.155-159, 2012. ,
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease, J Thorac Oncol, vol.10, pp.156-163, 2015. ,
Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer, N Engl J Med, vol.376, pp.629-640, 2017. ,
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer, Cancer Chemother Pharmacol, vol.70, pp.399-405, 2012. ,
Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non-small cell lung cancer (NSCLC): Updated results from BLOOM, a phase I study, J Clin. Oncol, vol.34, p.9002, 2016. ,
Intracranial efficacy of crizotinib versus chemotherapy in patients with advanced ALK-positive non-small-cell lung cancer: results from PROFILE 1014, J Clin Oncol, vol.34, pp.2858-2865, 2016. ,
Targeting brain metastases in ALKrearranged non-small-cell lung cancer, Lancet Oncol, vol.16, pp.510-521, 2015. ,
Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer, N Engl J Med, vol.373, pp.123-135, 2015. ,
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer, N Engl J Med, vol.373, pp.1627-1639, 2015. ,
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial, Lancet, vol.387, pp.1540-1550, 2016. ,
Atezolizumab versus docetaxel in patients with previously treated nonsmall-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial, Lancet, vol.389, pp.255-265, 2017. ,
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial, Lancet Oncol, vol.17, pp.976-983, 2016. ,
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial, Lancet Oncol, vol.13, pp.459-465, 2012. ,
Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients, Acta Derm Venereol, vol.94, pp.45-49, 2014. ,
Melanoma in the brain: biology and therapeutic options, Melanoma Res, vol.22, pp.177-183, 2012. ,
Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study, Eur J Cancer, vol.50, pp.611-621, 2014. ,
Vemurafenib in the French temporary authorization for use metastatic melanoma cohort: a singlecentre trial, Melanoma Res, vol.24, pp.75-82, 2014. ,
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial, Lancet Oncol, vol.13, pp.1087-1095, 2012. ,
Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?, J Neurooncol, vol.38, pp.151-157, 1998. ,
Systemic high-dose intravenous methotrexate for central nervous system metastases, J Neurooncol, vol.78, pp.255-260, 2006. ,
Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series, Neurol Sci, vol.36, pp.1691-1693, 2015. ,
Cerebral distribution of immunoconjugate after treatment for neoplastic meningitis using an intrathecal radiolabeled monoclonal antibody, Neurosurgery, vol.25, pp.253-258, 1989. ,
Spinal cord penetration of intrathecally administered cytarabine and methotrexate: a quantitative autoradiographic study, J Natl Cancer Inst, vol.80, pp.1211-1216, 1988. ,
Intrathecal administration of topotecan in nonhuman primates, Cancer Chemother Pharmacol, vol.36, pp.121-124, 1995. ,
Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis, Cancer, vol.116, pp.1947-1952, 2010. ,
A randomized phase III/ IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitis, J Clin Oncol, vol.24, p.1528, 2006. ,
Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients, J Neurooncol, vol.124, pp.317-323, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02939512
Stereotactic catheter placement for Ommaya reservoirs, J Clin Neurosci, vol.27, pp.44-47, 2016. ,
Image guidance for placement of Ommaya reservoirs: comparison of fluoroscopy and frameless stereotactic navigation in 145 patients, World Neurosurg, vol.93, pp.154-158, 2016. ,
Ventriculolumbar perfusion chemotherapy with methotrexate for treating leptomeningeal carcinomatosis: a Phase II Study, Oncologist, vol.19, pp.1044-1045, 2014. ,
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group, J Clin Oncol, vol.11, pp.561-569, 1993. ,
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors, Clin Cancer Res, vol.5, pp.3394-3402, 1999. ,
A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis, J Clin Oncol, vol.5, pp.1655-1662, 1987. ,
Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis, Cancer, vol.97, pp.3053-3060, 2003. ,
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis, Breast Cancer Res Treat, vol.139, pp.13-22, 2013. ,
Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases, Neurology, vol.46, pp.1674-1677, 1996. ,
Radioisotope CSF flow studies in leptomeningeal metastases, J Neurooncol, vol.38, pp.135-140, 1998. ,
Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: a prospective and single-arm study, Int J Cancer, vol.139, pp.1864-1872, 2016. ,
Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology, Cancer, vol.115, pp.1941-1946, 2009. ,
Epilepsy meets cancer: when, why, and what to do about it, Lancet Oncol, vol.13, pp.375-382, 2012. ,
Antiepileptic drugs for preventing seizures in people with brain tumors, Cochrane Database Syst Rev, vol.004424, 2008. ,
The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases, Clin Neurol Neurosurg, vol.119, pp.80-83, 2014. ,
Role of ventriculoperitoneal shunting in patients with neoplasms of the central nervous system: an analysis of 59 cases, Mol Clin Oncol, vol.3, pp.1381-1386, 2015. ,
Lumboperitoneal shunt for the treatment of leptomeningeal metastasis, Med Hypotheses, vol.84, pp.506-508, 2015. ,
Palliative lumboperitoneal shunt for leptomeningeal metastasis-related hydrocephalus: a case series, Palliat Med, vol.31, pp.93-96, 2017. ,
on behalf of the European Association of Neuro-Oncology palliative care task force. EANO guidelines for palliative care in adult glioma patients, Lancet Oncol, vol.18, pp.330-340, 2017. ,
Guidance for the preparation of neurological management guidelines by EFNS scientific task forcesrevised recommendations, Eur J Neurol, vol.11, pp.577-581, 2004. ,
Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients, Clin Infect Dis, vol.33, pp.139-144, 2001. ,